This research report provides a comprehensive analysis of the Lung Cancer Diagnosis and Therapeutics market, focusing on the current trends, market dynamics, and future prospects. The report explores the global Lung Cancer Diagnosis and Therapeutics market, including major regions such as North America, Europe, Asia-Pacific, and emerging markets. It also examines key factors driving the growth of Lung Cancer Diagnosis and Therapeutics, challenges faced by the industry, and potential opportunities for market players.
The global Lung Cancer Diagnosis and Therapeutics market has witnessed rapid growth in recent years, driven by increasing environmental concerns, government incentives, and advancements in technology. The Lung Cancer Diagnosis and Therapeutics market presents opportunities for various stakeholders, including Hospitals, Cancer Research Centers. Collaboration between the private sector and governments can accelerate the development of supportive policies, research and development efforts, and investment in Lung Cancer Diagnosis and Therapeutics market. Additionally, the growing consumer demand present avenues for market expansion.
The global Lung Cancer Diagnosis and Therapeutics market was valued at US$ million in 2023 and is projected to reach US$ million by 2030, at a CAGR of % during the forecast period.
Key Features:
The research report on the Lung Cancer Diagnosis and Therapeutics market includes several key features to provide comprehensive insights and facilitate decision-making for stakeholders.
Executive Summary: The report provides overview of the key findings, market trends, and major insights of the Lung Cancer Diagnosis and Therapeutics market.
Market Overview: The report provides a comprehensive overview of the Lung Cancer Diagnosis and Therapeutics market, including its definition, historical development, and current market size. It covers market segmentation by Type (e.g., Non-Small Cell Lung Cancer, Small Cell Lung Cancer), region, and application, highlighting the key drivers, challenges, and opportunities within each segment.
Market Dynamics: The report analyses the market dynamics driving the growth and development of the Lung Cancer Diagnosis and Therapeutics market. The report includes an assessment of government policies and regulations, technological advancements, consumer trends and preferences, infrastructure development, and industry collaborations. This analysis helps stakeholders understand the factors influencing the Lung Cancer Diagnosis and Therapeutics market's trajectory.
Competitive Landscape: The report provides an in-depth analysis of the competitive landscape within the Lung Cancer Diagnosis and Therapeutics market. It includes profiles of major market players, their market share, strategies, product portfolios, and recent developments.
Market Segmentation and Forecast: The report segment the Lung Cancer Diagnosis and Therapeutics market based on various parameters, such as by Type, region, and by Application. It provides market size and growth forecasts for each segment, supported by quantitative data and analysis. This helps stakeholders identify growth opportunities and make informed investment decisions.
Technological Trends: The report should highlight the key technological trends shaping the Lung Cancer Diagnosis and Therapeutics market, such as advancements in Type One technology and emerging substitutes. It analyses the impact of these trends on market growth, adoption rates, and consumer preferences.
Market Challenges and Opportunities: The report identify and analyses the major challenges faced by the Lung Cancer Diagnosis and Therapeutics market, such as technical bottleneck, cost limitations, and high entry barrier. It also highlights the opportunities for market growth, such as government incentives, emerging markets, and collaborations between stakeholders.
Regulatory and Policy Analysis: The report should assess the regulatory and policy landscape for Lung Cancer Diagnosis and Therapeutics, including government incentives, emission standards, and infrastructure development plans. It should analyse the impact of these policies on market growth and provide insights into future regulatory developments.
Recommendations and Conclusion: The report conclude with actionable recommendations for stakeholders, such as Application One Consumer, policymakers, investors, and infrastructure providers. These recommendations should be based on the research findings and address key challenges and opportunities within the Lung Cancer Diagnosis and Therapeutics market.
Supporting Data and Appendices: The report include supporting data, charts, and graphs to substantiate the analysis and findings. It also includes appendices with additional detailed information, such as data sources, survey questionnaires, and detailed market forecasts.
Market Segmentation
Lung Cancer Diagnosis and Therapeutics market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Market segment by Type
Non-Small Cell Lung Cancer
Small Cell Lung Cancer
Market segment by Application
Hospitals
Cancer Research Centers
Global Lung Cancer Diagnosis and Therapeutics Market Segment Percentages, By Region and Country, 2023 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Major players covered
AstraZeneca
Eli Lilly
Sanofi
ArQule
Daiichi Sankyo
Celgene
Merck
Pfizer
Boehringer Ingelheim
Roche
Genentech
GSK
Pharmacyclics
Novartis
Bayer
Bristol-Myers Squibb
Eisai
AbbVie
Outline of Major Chapters:
Chapter 1: Introduces the definition of Lung Cancer Diagnosis and Therapeutics, market overview.
Chapter 2: Global Lung Cancer Diagnosis and Therapeutics market size in revenue.
Chapter 3: Detailed analysis of Lung Cancer Diagnosis and Therapeutics company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Lung Cancer Diagnosis and Therapeutics in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Lung Cancer Diagnosis and Therapeutics Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Lung Cancer Diagnosis and Therapeutics Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Lung Cancer Diagnosis and Therapeutics Overall Market Size
2.1 Global Lung Cancer Diagnosis and Therapeutics Market Size: 2023 VS 2030
2.2 Global Lung Cancer Diagnosis and Therapeutics Market Size, Prospects & Forecasts: 2019-2030
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Lung Cancer Diagnosis and Therapeutics Players in Global Market
3.2 Top Global Lung Cancer Diagnosis and Therapeutics Companies Ranked by Revenue
3.3 Global Lung Cancer Diagnosis and Therapeutics Revenue by Companies
3.4 Top 3 and Top 5 Lung Cancer Diagnosis and Therapeutics Companies in Global Market, by Revenue in 2023
3.5 Global Companies Lung Cancer Diagnosis and Therapeutics Product Type
3.6 Tier 1, Tier 2 and Tier 3 Lung Cancer Diagnosis and Therapeutics Players in Global Market
3.6.1 List of Global Tier 1 Lung Cancer Diagnosis and Therapeutics Companies
3.6.2 List of Global Tier 2 and Tier 3 Lung Cancer Diagnosis and Therapeutics Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Lung Cancer Diagnosis and Therapeutics Market Size Markets, 2023 & 2030
4.1.2 Non-Small Cell Lung Cancer
4.1.3 Small Cell Lung Cancer
4.2 By Type - Global Lung Cancer Diagnosis and Therapeutics Revenue & Forecasts
4.2.1 By Type - Global Lung Cancer Diagnosis and Therapeutics Revenue, 2019-2024
4.2.2 By Type - Global Lung Cancer Diagnosis and Therapeutics Revenue, 2025-2030
4.2.3 By Type - Global Lung Cancer Diagnosis and Therapeutics Revenue Market Share, 2019-2030
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Lung Cancer Diagnosis and Therapeutics Market Size, 2023 & 2030
5.1.2 Hospitals
5.1.3 Cancer Research Centers
5.2 By Application - Global Lung Cancer Diagnosis and Therapeutics Revenue & Forecasts
5.2.1 By Application - Global Lung Cancer Diagnosis and Therapeutics Revenue, 2019-2024
5.2.2 By Application - Global Lung Cancer Diagnosis and Therapeutics Revenue, 2025-2030
5.2.3 By Application - Global Lung Cancer Diagnosis and Therapeutics Revenue Market Share, 2019-2030
6 Sights by Region
6.1 By Region - Global Lung Cancer Diagnosis and Therapeutics Market Size, 2023 & 2030
6.2 By Region - Global Lung Cancer Diagnosis and Therapeutics Revenue & Forecasts
6.2.1 By Region - Global Lung Cancer Diagnosis and Therapeutics Revenue, 2019-2024
6.2.2 By Region - Global Lung Cancer Diagnosis and Therapeutics Revenue, 2025-2030
6.2.3 By Region - Global Lung Cancer Diagnosis and Therapeutics Revenue Market Share, 2019-2030
6.3 North America
6.3.1 By Country - North America Lung Cancer Diagnosis and Therapeutics Revenue, 2019-2030
6.3.2 US Lung Cancer Diagnosis and Therapeutics Market Size, 2019-2030
6.3.3 Canada Lung Cancer Diagnosis and Therapeutics Market Size, 2019-2030
6.3.4 Mexico Lung Cancer Diagnosis and Therapeutics Market Size, 2019-2030
6.4 Europe
6.4.1 By Country - Europe Lung Cancer Diagnosis and Therapeutics Revenue, 2019-2030
6.4.2 Germany Lung Cancer Diagnosis and Therapeutics Market Size, 2019-2030
6.4.3 France Lung Cancer Diagnosis and Therapeutics Market Size, 2019-2030
6.4.4 U.K. Lung Cancer Diagnosis and Therapeutics Market Size, 2019-2030
6.4.5 Italy Lung Cancer Diagnosis and Therapeutics Market Size, 2019-2030
6.4.6 Russia Lung Cancer Diagnosis and Therapeutics Market Size, 2019-2030
6.4.7 Nordic Countries Lung Cancer Diagnosis and Therapeutics Market Size, 2019-2030
6.4.8 Benelux Lung Cancer Diagnosis and Therapeutics Market Size, 2019-2030
6.5 Asia
6.5.1 By Region - Asia Lung Cancer Diagnosis and Therapeutics Revenue, 2019-2030
6.5.2 China Lung Cancer Diagnosis and Therapeutics Market Size, 2019-2030
6.5.3 Japan Lung Cancer Diagnosis and Therapeutics Market Size, 2019-2030
6.5.4 South Korea Lung Cancer Diagnosis and Therapeutics Market Size, 2019-2030
6.5.5 Southeast Asia Lung Cancer Diagnosis and Therapeutics Market Size, 2019-2030
6.5.6 India Lung Cancer Diagnosis and Therapeutics Market Size, 2019-2030
6.6 South America
6.6.1 By Country - South America Lung Cancer Diagnosis and Therapeutics Revenue, 2019-2030
6.6.2 Brazil Lung Cancer Diagnosis and Therapeutics Market Size, 2019-2030
6.6.3 Argentina Lung Cancer Diagnosis and Therapeutics Market Size, 2019-2030
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Lung Cancer Diagnosis and Therapeutics Revenue, 2019-2030
6.7.2 Turkey Lung Cancer Diagnosis and Therapeutics Market Size, 2019-2030
6.7.3 Israel Lung Cancer Diagnosis and Therapeutics Market Size, 2019-2030
6.7.4 Saudi Arabia Lung Cancer Diagnosis and Therapeutics Market Size, 2019-2030
6.7.5 UAE Lung Cancer Diagnosis and Therapeutics Market Size, 2019-2030
7 Lung Cancer Diagnosis and Therapeutics Companies Profiles
7.1 AstraZeneca
7.1.1 AstraZeneca Company Summary
7.1.2 AstraZeneca Business Overview
7.1.3 AstraZeneca Lung Cancer Diagnosis and Therapeutics Major Product Offerings
7.1.4 AstraZeneca Lung Cancer Diagnosis and Therapeutics Revenue in Global Market (2019-2024)
7.1.5 AstraZeneca Key News & Latest Developments
7.2 Eli Lilly
7.2.1 Eli Lilly Company Summary
7.2.2 Eli Lilly Business Overview
7.2.3 Eli Lilly Lung Cancer Diagnosis and Therapeutics Major Product Offerings
7.2.4 Eli Lilly Lung Cancer Diagnosis and Therapeutics Revenue in Global Market (2019-2024)
7.2.5 Eli Lilly Key News & Latest Developments
7.3 Sanofi
7.3.1 Sanofi Company Summary
7.3.2 Sanofi Business Overview
7.3.3 Sanofi Lung Cancer Diagnosis and Therapeutics Major Product Offerings
7.3.4 Sanofi Lung Cancer Diagnosis and Therapeutics Revenue in Global Market (2019-2024)
7.3.5 Sanofi Key News & Latest Developments
7.4 ArQule
7.4.1 ArQule Company Summary
7.4.2 ArQule Business Overview
7.4.3 ArQule Lung Cancer Diagnosis and Therapeutics Major Product Offerings
7.4.4 ArQule Lung Cancer Diagnosis and Therapeutics Revenue in Global Market (2019-2024)
7.4.5 ArQule Key News & Latest Developments
7.5 Daiichi Sankyo
7.5.1 Daiichi Sankyo Company Summary
7.5.2 Daiichi Sankyo Business Overview
7.5.3 Daiichi Sankyo Lung Cancer Diagnosis and Therapeutics Major Product Offerings
7.5.4 Daiichi Sankyo Lung Cancer Diagnosis and Therapeutics Revenue in Global Market (2019-2024)
7.5.5 Daiichi Sankyo Key News & Latest Developments
7.6 Celgene
7.6.1 Celgene Company Summary
7.6.2 Celgene Business Overview
7.6.3 Celgene Lung Cancer Diagnosis and Therapeutics Major Product Offerings
7.6.4 Celgene Lung Cancer Diagnosis and Therapeutics Revenue in Global Market (2019-2024)
7.6.5 Celgene Key News & Latest Developments
7.7 Merck
7.7.1 Merck Company Summary
7.7.2 Merck Business Overview
7.7.3 Merck Lung Cancer Diagnosis and Therapeutics Major Product Offerings
7.7.4 Merck Lung Cancer Diagnosis and Therapeutics Revenue in Global Market (2019-2024)
7.7.5 Merck Key News & Latest Developments
7.8 Pfizer
7.8.1 Pfizer Company Summary
7.8.2 Pfizer Business Overview
7.8.3 Pfizer Lung Cancer Diagnosis and Therapeutics Major Product Offerings
7.8.4 Pfizer Lung Cancer Diagnosis and Therapeutics Revenue in Global Market (2019-2024)
7.8.5 Pfizer Key News & Latest Developments
7.9 Boehringer Ingelheim
7.9.1 Boehringer Ingelheim Company Summary
7.9.2 Boehringer Ingelheim Business Overview
7.9.3 Boehringer Ingelheim Lung Cancer Diagnosis and Therapeutics Major Product Offerings
7.9.4 Boehringer Ingelheim Lung Cancer Diagnosis and Therapeutics Revenue in Global Market (2019-2024)
7.9.5 Boehringer Ingelheim Key News & Latest Developments
7.10 Roche
7.10.1 Roche Company Summary
7.10.2 Roche Business Overview
7.10.3 Roche Lung Cancer Diagnosis and Therapeutics Major Product Offerings
7.10.4 Roche Lung Cancer Diagnosis and Therapeutics Revenue in Global Market (2019-2024)
7.10.5 Roche Key News & Latest Developments
7.11 Genentech
7.11.1 Genentech Company Summary
7.11.2 Genentech Business Overview
7.11.3 Genentech Lung Cancer Diagnosis and Therapeutics Major Product Offerings
7.11.4 Genentech Lung Cancer Diagnosis and Therapeutics Revenue in Global Market (2019-2024)
7.11.5 Genentech Key News & Latest Developments
7.12 GSK
7.12.1 GSK Company Summary
7.12.2 GSK Business Overview
7.12.3 GSK Lung Cancer Diagnosis and Therapeutics Major Product Offerings
7.12.4 GSK Lung Cancer Diagnosis and Therapeutics Revenue in Global Market (2019-2024)
7.12.5 GSK Key News & Latest Developments
7.13 Pharmacyclics
7.13.1 Pharmacyclics Company Summary
7.13.2 Pharmacyclics Business Overview
7.13.3 Pharmacyclics Lung Cancer Diagnosis and Therapeutics Major Product Offerings
7.13.4 Pharmacyclics Lung Cancer Diagnosis and Therapeutics Revenue in Global Market (2019-2024)
7.13.5 Pharmacyclics Key News & Latest Developments
7.14 Novartis
7.14.1 Novartis Company Summary
7.14.2 Novartis Business Overview
7.14.3 Novartis Lung Cancer Diagnosis and Therapeutics Major Product Offerings
7.14.4 Novartis Lung Cancer Diagnosis and Therapeutics Revenue in Global Market (2019-2024)
7.14.5 Novartis Key News & Latest Developments
7.15 Bayer
7.15.1 Bayer Company Summary
7.15.2 Bayer Business Overview
7.15.3 Bayer Lung Cancer Diagnosis and Therapeutics Major Product Offerings
7.15.4 Bayer Lung Cancer Diagnosis and Therapeutics Revenue in Global Market (2019-2024)
7.15.5 Bayer Key News & Latest Developments
7.16 Bristol-Myers Squibb
7.16.1 Bristol-Myers Squibb Company Summary
7.16.2 Bristol-Myers Squibb Business Overview
7.16.3 Bristol-Myers Squibb Lung Cancer Diagnosis and Therapeutics Major Product Offerings
7.16.4 Bristol-Myers Squibb Lung Cancer Diagnosis and Therapeutics Revenue in Global Market (2019-2024)
7.16.5 Bristol-Myers Squibb Key News & Latest Developments
7.17 Eisai
7.17.1 Eisai Company Summary
7.17.2 Eisai Business Overview
7.17.3 Eisai Lung Cancer Diagnosis and Therapeutics Major Product Offerings
7.17.4 Eisai Lung Cancer Diagnosis and Therapeutics Revenue in Global Market (2019-2024)
7.17.5 Eisai Key News & Latest Developments
7.18 AbbVie
7.18.1 AbbVie Company Summary
7.18.2 AbbVie Business Overview
7.18.3 AbbVie Lung Cancer Diagnosis and Therapeutics Major Product Offerings
7.18.4 AbbVie Lung Cancer Diagnosis and Therapeutics Revenue in Global Market (2019-2024)
7.18.5 AbbVie Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Lung Cancer Diagnosis and Therapeutics Market Opportunities & Trends in Global Market
Table 2. Lung Cancer Diagnosis and Therapeutics Market Drivers in Global Market
Table 3. Lung Cancer Diagnosis and Therapeutics Market Restraints in Global Market
Table 4. Key Players of Lung Cancer Diagnosis and Therapeutics in Global Market
Table 5. Top Lung Cancer Diagnosis and Therapeutics Players in Global Market, Ranking by Revenue (2023)
Table 6. Global Lung Cancer Diagnosis and Therapeutics Revenue by Companies, (US$, Mn), 2019-2024
Table 7. Global Lung Cancer Diagnosis and Therapeutics Revenue Share by Companies, 2019-2024
Table 8. Global Companies Lung Cancer Diagnosis and Therapeutics Product Type
Table 9. List of Global Tier 1 Lung Cancer Diagnosis and Therapeutics Companies, Revenue (US$, Mn) in 2023 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Lung Cancer Diagnosis and Therapeutics Companies, Revenue (US$, Mn) in 2023 and Market Share
Table 11. By Type ? Global Lung Cancer Diagnosis and Therapeutics Revenue, (US$, Mn), 2023 & 2030
Table 12. By Type - Lung Cancer Diagnosis and Therapeutics Revenue in Global (US$, Mn), 2019-2024
Table 13. By Type - Lung Cancer Diagnosis and Therapeutics Revenue in Global (US$, Mn), 2025-2030
Table 14. By Application ? Global Lung Cancer Diagnosis and Therapeutics Revenue, (US$, Mn), 2023 & 2030
Table 15. By Application - Lung Cancer Diagnosis and Therapeutics Revenue in Global (US$, Mn), 2019-2024
Table 16. By Application - Lung Cancer Diagnosis and Therapeutics Revenue in Global (US$, Mn), 2025-2030
Table 17. By Region ? Global Lung Cancer Diagnosis and Therapeutics Revenue, (US$, Mn), 2023 & 2030
Table 18. By Region - Global Lung Cancer Diagnosis and Therapeutics Revenue (US$, Mn), 2019-2024
Table 19. By Region - Global Lung Cancer Diagnosis and Therapeutics Revenue (US$, Mn), 2025-2030
Table 20. By Country - North America Lung Cancer Diagnosis and Therapeutics Revenue, (US$, Mn), 2019-2024
Table 21. By Country - North America Lung Cancer Diagnosis and Therapeutics Revenue, (US$, Mn), 2025-2030
Table 22. By Country - Europe Lung Cancer Diagnosis and Therapeutics Revenue, (US$, Mn), 2019-2024
Table 23. By Country - Europe Lung Cancer Diagnosis and Therapeutics Revenue, (US$, Mn), 2025-2030
Table 24. By Region - Asia Lung Cancer Diagnosis and Therapeutics Revenue, (US$, Mn), 2019-2024
Table 25. By Region - Asia Lung Cancer Diagnosis and Therapeutics Revenue, (US$, Mn), 2025-2030
Table 26. By Country - South America Lung Cancer Diagnosis and Therapeutics Revenue, (US$, Mn), 2019-2024
Table 27. By Country - South America Lung Cancer Diagnosis and Therapeutics Revenue, (US$, Mn), 2025-2030
Table 28. By Country - Middle East & Africa Lung Cancer Diagnosis and Therapeutics Revenue, (US$, Mn), 2019-2024
Table 29. By Country - Middle East & Africa Lung Cancer Diagnosis and Therapeutics Revenue, (US$, Mn), 2025-2030
Table 30. AstraZeneca Company Summary
Table 31. AstraZeneca Lung Cancer Diagnosis and Therapeutics Product Offerings
Table 32. AstraZeneca Lung Cancer Diagnosis and Therapeutics Revenue (US$, Mn) & (2019-2024)
Table 33. AstraZeneca Key News & Latest Developments
Table 34. Eli Lilly Company Summary
Table 35. Eli Lilly Lung Cancer Diagnosis and Therapeutics Product Offerings
Table 36. Eli Lilly Lung Cancer Diagnosis and Therapeutics Revenue (US$, Mn) & (2019-2024)
Table 37. Eli Lilly Key News & Latest Developments
Table 38. Sanofi Company Summary
Table 39. Sanofi Lung Cancer Diagnosis and Therapeutics Product Offerings
Table 40. Sanofi Lung Cancer Diagnosis and Therapeutics Revenue (US$, Mn) & (2019-2024)
Table 41. Sanofi Key News & Latest Developments
Table 42. ArQule Company Summary
Table 43. ArQule Lung Cancer Diagnosis and Therapeutics Product Offerings
Table 44. ArQule Lung Cancer Diagnosis and Therapeutics Revenue (US$, Mn) & (2019-2024)
Table 45. ArQule Key News & Latest Developments
Table 46. Daiichi Sankyo Company Summary
Table 47. Daiichi Sankyo Lung Cancer Diagnosis and Therapeutics Product Offerings
Table 48. Daiichi Sankyo Lung Cancer Diagnosis and Therapeutics Revenue (US$, Mn) & (2019-2024)
Table 49. Daiichi Sankyo Key News & Latest Developments
Table 50. Celgene Company Summary
Table 51. Celgene Lung Cancer Diagnosis and Therapeutics Product Offerings
Table 52. Celgene Lung Cancer Diagnosis and Therapeutics Revenue (US$, Mn) & (2019-2024)
Table 53. Celgene Key News & Latest Developments
Table 54. Merck Company Summary
Table 55. Merck Lung Cancer Diagnosis and Therapeutics Product Offerings
Table 56. Merck Lung Cancer Diagnosis and Therapeutics Revenue (US$, Mn) & (2019-2024)
Table 57. Merck Key News & Latest Developments
Table 58. Pfizer Company Summary
Table 59. Pfizer Lung Cancer Diagnosis and Therapeutics Product Offerings
Table 60. Pfizer Lung Cancer Diagnosis and Therapeutics Revenue (US$, Mn) & (2019-2024)
Table 61. Pfizer Key News & Latest Developments
Table 62. Boehringer Ingelheim Company Summary
Table 63. Boehringer Ingelheim Lung Cancer Diagnosis and Therapeutics Product Offerings
Table 64. Boehringer Ingelheim Lung Cancer Diagnosis and Therapeutics Revenue (US$, Mn) & (2019-2024)
Table 65. Boehringer Ingelheim Key News & Latest Developments
Table 66. Roche Company Summary
Table 67. Roche Lung Cancer Diagnosis and Therapeutics Product Offerings
Table 68. Roche Lung Cancer Diagnosis and Therapeutics Revenue (US$, Mn) & (2019-2024)
Table 69. Roche Key News & Latest Developments
Table 70. Genentech Company Summary
Table 71. Genentech Lung Cancer Diagnosis and Therapeutics Product Offerings
Table 72. Genentech Lung Cancer Diagnosis and Therapeutics Revenue (US$, Mn) & (2019-2024)
Table 73. Genentech Key News & Latest Developments
Table 74. GSK Company Summary
Table 75. GSK Lung Cancer Diagnosis and Therapeutics Product Offerings
Table 76. GSK Lung Cancer Diagnosis and Therapeutics Revenue (US$, Mn) & (2019-2024)
Table 77. GSK Key News & Latest Developments
Table 78. Pharmacyclics Company Summary
Table 79. Pharmacyclics Lung Cancer Diagnosis and Therapeutics Product Offerings
Table 80. Pharmacyclics Lung Cancer Diagnosis and Therapeutics Revenue (US$, Mn) & (2019-2024)
Table 81. Pharmacyclics Key News & Latest Developments
Table 82. Novartis Company Summary
Table 83. Novartis Lung Cancer Diagnosis and Therapeutics Product Offerings
Table 84. Novartis Lung Cancer Diagnosis and Therapeutics Revenue (US$, Mn) & (2019-2024)
Table 85. Novartis Key News & Latest Developments
Table 86. Bayer Company Summary
Table 87. Bayer Lung Cancer Diagnosis and Therapeutics Product Offerings
Table 88. Bayer Lung Cancer Diagnosis and Therapeutics Revenue (US$, Mn) & (2019-2024)
Table 89. Bayer Key News & Latest Developments
Table 90. Bristol-Myers Squibb Company Summary
Table 91. Bristol-Myers Squibb Lung Cancer Diagnosis and Therapeutics Product Offerings
Table 92. Bristol-Myers Squibb Lung Cancer Diagnosis and Therapeutics Revenue (US$, Mn) & (2019-2024)
Table 93. Bristol-Myers Squibb Key News & Latest Developments
Table 94. Eisai Company Summary
Table 95. Eisai Lung Cancer Diagnosis and Therapeutics Product Offerings
Table 96. Eisai Lung Cancer Diagnosis and Therapeutics Revenue (US$, Mn) & (2019-2024)
Table 97. Eisai Key News & Latest Developments
Table 98. AbbVie Company Summary
Table 99. AbbVie Lung Cancer Diagnosis and Therapeutics Product Offerings
Table 100. AbbVie Lung Cancer Diagnosis and Therapeutics Revenue (US$, Mn) & (2019-2024)
Table 101. AbbVie Key News & Latest Developments
List of Figures
Figure 1. Lung Cancer Diagnosis and Therapeutics Segment by Type in 2023
Figure 2. Lung Cancer Diagnosis and Therapeutics Segment by Application in 2023
Figure 3. Global Lung Cancer Diagnosis and Therapeutics Market Overview: 2023
Figure 4. Key Caveats
Figure 5. Global Lung Cancer Diagnosis and Therapeutics Market Size: 2023 VS 2030 (US$, Mn)
Figure 6. Global Lung Cancer Diagnosis and Therapeutics Revenue, 2019-2030 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Lung Cancer Diagnosis and Therapeutics Revenue in 2023
Figure 8. By Type - Global Lung Cancer Diagnosis and Therapeutics Revenue Market Share, 2019-2030
Figure 9. By Application - Global Lung Cancer Diagnosis and Therapeutics Revenue Market Share, 2019-2030
Figure 10. By Type - Global Lung Cancer Diagnosis and Therapeutics Revenue, (US$, Mn), 2023 & 2030
Figure 11. By Type - Global Lung Cancer Diagnosis and Therapeutics Revenue Market Share, 2019-2030
Figure 12. By Application - Global Lung Cancer Diagnosis and Therapeutics Revenue, (US$, Mn), 2023 & 2030
Figure 13. By Application - Global Lung Cancer Diagnosis and Therapeutics Revenue Market Share, 2019-2030
Figure 14. By Region - Global Lung Cancer Diagnosis and Therapeutics Revenue Market Share, 2019-2030
Figure 15. By Country - North America Lung Cancer Diagnosis and Therapeutics Revenue Market Share, 2019-2030
Figure 16. US Lung Cancer Diagnosis and Therapeutics Revenue, (US$, Mn), 2019-2030
Figure 17. Canada Lung Cancer Diagnosis and Therapeutics Revenue, (US$, Mn), 2019-2030
Figure 18. Mexico Lung Cancer Diagnosis and Therapeutics Revenue, (US$, Mn), 2019-2030
Figure 19. By Country - Europe Lung Cancer Diagnosis and Therapeutics Revenue Market Share, 2019-2030
Figure 20. Germany Lung Cancer Diagnosis and Therapeutics Revenue, (US$, Mn), 2019-2030
Figure 21. France Lung Cancer Diagnosis and Therapeutics Revenue, (US$, Mn), 2019-2030
Figure 22. U.K. Lung Cancer Diagnosis and Therapeutics Revenue, (US$, Mn), 2019-2030
Figure 23. Italy Lung Cancer Diagnosis and Therapeutics Revenue, (US$, Mn), 2019-2030
Figure 24. Russia Lung Cancer Diagnosis and Therapeutics Revenue, (US$, Mn), 2019-2030
Figure 25. Nordic Countries Lung Cancer Diagnosis and Therapeutics Revenue, (US$, Mn), 2019-2030
Figure 26. Benelux Lung Cancer Diagnosis and Therapeutics Revenue, (US$, Mn), 2019-2030
Figure 27. By Region - Asia Lung Cancer Diagnosis and Therapeutics Revenue Market Share, 2019-2030
Figure 28. China Lung Cancer Diagnosis and Therapeutics Revenue, (US$, Mn), 2019-2030
Figure 29. Japan Lung Cancer Diagnosis and Therapeutics Revenue, (US$, Mn), 2019-2030
Figure 30. South Korea Lung Cancer Diagnosis and Therapeutics Revenue, (US$, Mn), 2019-2030
Figure 31. Southeast Asia Lung Cancer Diagnosis and Therapeutics Revenue, (US$, Mn), 2019-2030
Figure 32. India Lung Cancer Diagnosis and Therapeutics Revenue, (US$, Mn), 2019-2030
Figure 33. By Country - South America Lung Cancer Diagnosis and Therapeutics Revenue Market Share, 2019-2030
Figure 34. Brazil Lung Cancer Diagnosis and Therapeutics Revenue, (US$, Mn), 2019-2030
Figure 35. Argentina Lung Cancer Diagnosis and Therapeutics Revenue, (US$, Mn), 2019-2030
Figure 36. By Country - Middle East & Africa Lung Cancer Diagnosis and Therapeutics Revenue Market Share, 2019-2030
Figure 37. Turkey Lung Cancer Diagnosis and Therapeutics Revenue, (US$, Mn), 2019-2030
Figure 38. Israel Lung Cancer Diagnosis and Therapeutics Revenue, (US$, Mn), 2019-2030
Figure 39. Saudi Arabia Lung Cancer Diagnosis and Therapeutics Revenue, (US$, Mn), 2019-2030
Figure 40. UAE Lung Cancer Diagnosis and Therapeutics Revenue, (US$, Mn), 2019-2030
Figure 41. AstraZeneca Lung Cancer Diagnosis and Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 42. Eli Lilly Lung Cancer Diagnosis and Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 43. Sanofi Lung Cancer Diagnosis and Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 44. ArQule Lung Cancer Diagnosis and Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 45. Daiichi Sankyo Lung Cancer Diagnosis and Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 46. Celgene Lung Cancer Diagnosis and Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 47. Merck Lung Cancer Diagnosis and Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 48. Pfizer Lung Cancer Diagnosis and Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 49. Boehringer Ingelheim Lung Cancer Diagnosis and Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 50. Roche Lung Cancer Diagnosis and Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 51. Genentech Lung Cancer Diagnosis and Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 52. GSK Lung Cancer Diagnosis and Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 53. Pharmacyclics Lung Cancer Diagnosis and Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 54. Novartis Lung Cancer Diagnosis and Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 55. Bayer Lung Cancer Diagnosis and Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 56. Bristol-Myers Squibb Lung Cancer Diagnosis and Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 57. Eisai Lung Cancer Diagnosis and Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 58. AbbVie Lung Cancer Diagnosis and Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
